Clinical Trial Update: High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on a phase 1/2 study of high-dose peripheral blood stem cell transplantation with post-transplant cyclophosphamide for chroni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Drugs mentioned

• Cyclophosphamide (Cytoxan) (cyclophosphamide)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Chronic Granulomatous Disease Transplant | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING